Ipsen SA - Monthly information relative to the total number of voting rights and shares composing the share capital - April 2023

Ipsen Pharma

  

Monthly information relative to the total number of voting rights
and shares composing the share capital

(in accordance with Article L.233-8 II of the French Commercial Code and
Article 223-16 of the General Regulation of the Autorité des Marchés Financiers)

Market: Euronext Paris
ISIN Code: FR 0010259150
LEI: 549300M6SGDPB4Z94P11

Date	Total number of shares composing the share capital	Total number of voting rights (1)
30 April 2023	83,814,526	Gross total* of voting rights: 132,089,350
		Net total** of voting rights: 130,926,938

⁽¹⁾ Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10).

* Gross total = total number of voting rights attached to the total number of shares, including the number of shares which benefit of double voting rights and the number of treasury shares. The « Gross total » is used as a basis for the calculation of threshold crossings.

** Net total = total number of voting rights attached to the total number of shares – shares without voting rights.

Attachment

• Declaration relative to the total number of voting rights - April 2023